| AS-BRPT-113-02 |
Development of new anti-cancer drug targeting ENO1 |
Han-Chung Wu |
Institute of Cellular and Organismic Biology, Biomedical Translation Research Center |
2024/1/1~2026/12/31 |
| AS-BRPT-114-01 |
Targeting Novel LncRNA Myca-MYC Axis for Liver Cancer Therapy |
Yu-Ru Lee |
Institute of Biomedical Sciences, National Yang Ming Chiao Tung University, Taipei Veterans General Hospital |
2025/1/1~2027/12/31 |
| AS-BRPT-113-M01 |
Pre-Clinical Investigation of Prostate Cancer Neoantigen mRNA Vaccine |
Mi-Hua Tao |
Institute of Biomedical Sciences, Taipei Medical University |
2024/1/1~2026/12/31 |
| AS-BRPT-113-M02 |
Development of a Continuous Intelligent Automated mRNA Vaccine Production System Based on Fluidic Bioreactors |
Yi-Chung Tung |
Research Center for Applied Sciences |
2024/1/1~2026/12/31 |
| AS-BRTP-115-01 |
Clinical Translation of Targeted IL-17RB/MLK4 Therapies for Pancreatic Cancer Precision Medicine |
CHUN-MEI HU |
Genomics Research Center, National Yang Ming Chiao Tung University, National Taiwan University |
2026/1/1~2026/12/31 |
| AS-BRTP-115-02 |
Development of Cancer Vaccine-Engineered γδ T Cells for Enhanced Cancer Immunotherapy |
SHIH-YU CHEN |
Institute of Biomedical Sciences, National Taiwan University Hospital |
2026/1/1~2027/12/31 |